These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5338474)

  • 1. [The effect of a cholesterol lowering diet in male survivors of myocardial infarction. (A controlled clinical trial)].
    Leren P
    Nord Med; 1967 May; 77(21):658-61. PubMed ID: 5338474
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial.
    Leren P
    Acta Med Scand Suppl; 1966; 466():1-92. PubMed ID: 5228820
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of plasma-cholesterol-lowering diet in male survivors of myocardial infarction. A controlled clinical trial.
    Leren P
    Bull N Y Acad Med; 1968 Aug; 44(8):1012-20. PubMed ID: 4875746
    [No Abstract]   [Full Text] [Related]  

  • 4. ["Fat substitutes"--can nature be fooled?].
    Wolfram G
    Wien Klin Wochenschr; 1996 Nov; 108(22):701-4. PubMed ID: 9157715
    [No Abstract]   [Full Text] [Related]  

  • 5. The value of lowering cholesterol after myocardial infarction.
    Rossouw JE; Lewis B; Rifkind BM
    N Engl J Med; 1990 Oct; 323(16):1112-9. PubMed ID: 2215579
    [No Abstract]   [Full Text] [Related]  

  • 6. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled trial of soya-bean oil in myocardial infarction.
    Lancet; 1968 Sep; 2(7570):693-9. PubMed ID: 4175085
    [No Abstract]   [Full Text] [Related]  

  • 9. A controlled trial of the effect of linolenic acid on incidence of coronary heart disease. The Norwegian vegetable oil experiment of 1965-66.
    Natvig H; Borchgrevink CF; Dedichen J; Owren PA; Schiotz EH; Westlund K
    Scand J Clin Lab Invest Suppl; 1968; 105():1-20. PubMed ID: 5756076
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum cholesterol and risk of mortality and morbidity. A 3-year follow-up of 6,886 men.
    Westlund K; Nicolaysen R
    Scand J Clin Lab Invest Suppl; 1966; 87():1-19. PubMed ID: 5942122
    [No Abstract]   [Full Text] [Related]  

  • 11. Trends in the prevalence, awareness, treatment, and control of cardiovascular disease risk factors among noninstitutionalized patients with a history of myocardial infarction and stroke.
    Muntner P; DeSalvo KB; Wildman RP; Raggi P; He J; Whelton PK
    Am J Epidemiol; 2006 May; 163(10):913-20. PubMed ID: 16597707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambient air pollution is associated with increased risk of hospital cardiac readmissions of myocardial infarction survivors in five European cities.
    von Klot S; Peters A; Aalto P; Bellander T; Berglind N; D'Ippoliti D; Elosua R; Hörmann A; Kulmala M; Lanki T; Löwel H; Pekkanen J; Picciotto S; Sunyer J; Forastiere F;
    Circulation; 2005 Nov; 112(20):3073-9. PubMed ID: 16286602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The cholesterol hypothesis has been proved true at last].
    Huttunen J
    Duodecim; 1995; 111(5):385-6. PubMed ID: 8674438
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment.
    Wilhelmsen L; Pyörälä K; Wedel H; Cook T; Pedersen T; Kjekshus J
    Eur Heart J; 2001 Jul; 22(13):1119-27. PubMed ID: 11428852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clofibrate for prevention of myocardial infarction.
    Med Lett Drugs Ther; 1973 Apr; 15(9):37-8. PubMed ID: 4704699
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of lowering cholesterol on mortality].
    Schmidt JG
    Schweiz Med Wochenschr; 1993 Nov; 123(45):2150-5. PubMed ID: 8266036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol-lowering drugs. Some drugs with demonstrated efficacy but different benefits in primary and secondary prevention.
    Prescrire Int; 1999 Aug; 8(42):116-20. PubMed ID: 11503831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The optimal low-density lipoprotein is 50 to 70 mg/dl.
    Clendenning R
    J Am Coll Cardiol; 2005 May; 45(10):1732; author reply 1732. PubMed ID: 15893199
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma cholesterol lowering diet. The effect in male survivors of myocardial infarction.
    Leren P
    Minn Med; 1969 Aug; 52(8):1231-5. PubMed ID: 5804990
    [No Abstract]   [Full Text] [Related]  

  • 20. [Nutrition and dietetics for the aged].
    Piper W
    Hippokrates; 1967 Apr; 38(8):302-8. PubMed ID: 5591014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.